Evaluation of the effect of administration of two doses of dexmedetomidine in the prevention of chills, pain, nausea and vomiting after gallbladder surgery
Phase 3
Recruiting
- Conditions
- Elective surgery.
- Registration Number
- IRCT20200825048515N53
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Patients candidates for laparoscopic cholecystectomy
American Anesthesiologists Association (ASA) Classification I and II
Age category 65-18 years
Satisfaction to participate in the study
Exclusion Criteria
History of monoamine oxidase inhibitor (MAOI), tricyclic antidepressant (TCA), vasoactive, analgesic, opioid before surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chills. Timepoint: Every 15 minutes in recovery and every 6 hours in the ward up to 24 hours after surgery. Method of measurement: Observention.
- Secondary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: At the start of surgery, every 30 minutes during surgery, every 30 minutes in recovery, and every 6 hours in the ward for up to 24 hours after surgery. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: At the start of surgery, every 30 minutes during surgery, every 30 minutes in recovery, and every 6 hours in the ward for up to 24 hours after surgery. Method of measurement: Monitoring device.;Hear rate. Timepoint: At the start of surgery, every 30 minutes during surgery, every 30 minutes in recovery, and every 6 hours in the ward for up to 24 hours after surgery. Method of measurement: Monitoring device.